Research Calls
-
Upgrades:
- Alcoa (AA) upgraded to Equal-Weight from Underweight at Morgan Stanley; tgt raised to $36.50
- CytomX Therapeutics (CTMX) upgraded to Neutral from Underweight at JP Morgan
- Equity Residential (EQR) upgraded to Outperform from Market Perform at BMO Capital Markets; tgt raised to $70
- Euronet (EEFT) upgraded to Buy from Neutral at Citigroup; tgt raised to $120
- Federal Realty (FRT) upgraded to Buy from Hold at Deutsche Bank; tgt raised to $110
- Ingevity (NGVT) upgraded to Buy from Hold at Jefferies; tgt raised to $62
- L3Harris (LHX) upgraded to Overweight from Neutral at Alembic Global Advisors; tgt $238
- Northrop Grumman (NOC) upgraded to Overweight from Neutral at Alembic Global Advisors; tgt $532
- Papa John's (PZZA) upgraded to Hold from Sell at Stifel; tgt lowered to $60
- PPG Industries (PPG) upgraded to Buy from Neutral at Seaport Research Partners
- Provident Finl (PFS) upgraded to Buy from Neutral at DA Davidson; tgt raised to $20
- Robert Half (RHI) upgraded to Hold from Sell at Truist; tgt $72
- Sea Limited (SE) upgraded to Buy from Neutral at BofA Securities; tgt raised to $70
-
Downgrades:
- CNH Industrial (CNHI) downgraded to Neutral from Buy at BofA Securities
- CVB Financial (CVBF) downgraded to Market Perform from Outperform at Hovde Group; tgt $18
- OGE Energy (OGE) downgraded to Equal Weight from Overweight at Barclays; tgt $34
- Pacific Biosciences (PACB) downgraded to Neutral from Overweight at JP Morgan
- PPG Industries (PPG) downgraded to In-line from Outperform at Evercore ISI; tgt $152
- Prologis (PLD) downgraded to Market Perform from Outperform at BMO Capital Markets; tgt lowered to $112
- Southern Copper (SCCO) downgraded to Reduce from Hold at HSBC Securities; tgt $80
- UBS AG (UBS) downgraded to Neutral from Outperform at Exane BNP Paribas
- Western Digital (WDC) downgraded to Mkt Perform from Outperform at Raymond James
-
Others:
- 89bio (ETNB) resumed with a Buy at BofA Securities; tgt $30
- Agilon Health (AGL) initiated with a Neutral at Citigroup; tgt $6
- Akero Therapeutics (AKRO) resumed with a Neutral at BofA Securities; tgt $30
- Atour Lifestyle Hldgs. Ltd. (ATAT) initiated with an Outperform at Macquarie; tgt $26
- BellRing Brands (BRBR) initiated with a Buy at TD Cowen; tgt $64
- Boundless Bio (BOLD) initiated with an Outperform at Leerink Partners; tgt $25
- Boundless Bio (BOLD) initiated with a Buy at Guggenheim; tgt $24
- Boundless Bio (BOLD) initiated with an Overweight at Piper Sandler; tgt $20
- Cardiol Therapeutics (CRDL) initiated with a Buy at H.C. Wainwright; tgt $9
- Cisco (CSCO) resumed with a Neutral from Overweight at JP Morgan; tgt lowered to $53
- EastGroup (EGP) initiated with an Outperform at BMO Capital Markets; tgt $190
- enGene Holdings (ENGN) initiated with an Overweight at Wells Fargo; tgt $30
- Evolent Health (EVH) initiated with a Buy at Citigroup; tgt $40
- Citigroup opened 30-day Positive Catalyst Watch on ExlService (EXLS)
- GE Vernova (GEV) initiated with a Hold at Melius; tgt $147
- Healthpeak Properties (DOC) resumed with a Buy at Mizuho; tgt $22
- Hut 8 Mining (HUT) initiated with a Buy at The Benchmark Company; tgt $12
- Infinera (INFN) resumed with a Buy from Strong Buy at Needham; tgt $10
- Kinetik (KNTK) initiated with an Equal Weight at Barclays; tgt $40
- Kirby (KEX) initiated with an Outperform at Wolfe Research; tgt $126
- Kymera Therapeutics (KYMR) initiated with an Outperform at Oppenheimer; tgt $53
- Lucid Group (LCID) resumed with a Neutral at Citigroup; tgt $2.90
- Madrigal Pharmaceuticals (MDGL) initiated with an Underperform at BofA Securities; tgt $150
- Palmer Square Capital BDC (PSBD) initiated with a Neutral at Janney; tgt $17.50
- Prime Medicine (PRME) initiated with a Buy at Chardan Capital Markets; tgt $17
- Privia Health (PRVA) initiated with a Buy at Citigroup; tgt $25
- Rexford Industrial Realty (REXR) initiated with a Neutral at Wedbush; tgt $45
- Simply Good Foods (SMPL) initiated with a Hold at TD Cowen; tgt $34
- Stevanato Group S.p.A. (STVN) initiated with an Outperform at Exane BNP Paribas
- Ultragenyx Pharma (RARE) initiated with an Outperform at RBC Capital Mkts; tgt $77
- Deutsche Bank named Union Pacific (UNP) at Catalyst Call: Buy Idea